About Standing in the Gaap

Standing in the Gaap is an initiative created to help bridge the gaps in care for African Americans living with multiple myeloma.

The essence of the phrase “Standing in the Gaap” is: I am there for you, I have your back, I will provide the bridge to help you achieve your goals.

Celgene Corporation, a Bristol Myers Squibb company, has created the “Standing in the Gaap for African Americans with Multiple Myeloma” initiative to help spread the word about how multiple myeloma affects African Americans differently, in order to improve the quality of the care they receive.

Since 2016, the Standing in the Gaap initiative has expanded to include live educational events for patients and healthcare providers, as well as a thriving Facebook community of more than 61,000 members, and growing.

Have you joined the Standing in the Gaap community?

Like our page and get multiple myeloma resources right in your newsfeed.


This website is best viewed
using the horizontal display
on your tablet device.

This website is best viewed
using the vertical display
on your mobile device.